Nanoparticulate compositions of angiogenesis inhibitors

Details for Australian Patent Application No. 2009223108 (hide)

Owner Elan Pharma International Ltd.

Inventors Pruitt, John; Cary, Greta G.; MeriskoLiversidge, Elaine; Ryde, Tuula; Jain, Rajeev; Bosch, H. William; Walters, Amy

Agent Griffith Hack

Pub. Number AU-A-2009223108

PCT Pub. Number WO2009/114695

Priority 12/076,247 14.03.08 US

Filing date 12 March 2009

Wipo publication date 17 September 2009

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

Event Publications

16 September 2010 PCT application entered the National Phase

  PCT publication WO2009/114695 Priority application(s): WO2009/114695

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009223115-Recombinant production of authentic human proteins using human cell expression systems

2009223092-Treatment of Pompe disease with specific pharmacological chaperones and monitoring treatment using surrogate markers